Emerging Green Chemistry Market Ushers in a New Era of Sustainable Pharmaceutical Manufacturing
17 déc. 2024 05h00 HE
|
Research and Markets
Dublin, Dec. 17, 2024 (GLOBE NEWSWIRE) -- The "Green Chemistry Market: Focus on Green Chemistry Initiatives, Competitive Landscape of Green Chemistry Solution Providers, Emerging Mega Trends, Big...
Global Breakthrough Therapy Designation Market Set to Double by 2029 with Notable CAGR of 13.80%
13 déc. 2024 11h02 HE
|
Research and Markets
Dublin, Dec. 13, 2024 (GLOBE NEWSWIRE) -- The "Breakthrough Therapies: Market Dynamics and Investment Opportunities" report has been added to ResearchAndMarkets.com's offering.The Breakthrough...
Growth Trends in the Pharmaceutical Drying Equipment Market, 2024-2029: Increased Market Competition and High Demand for Generic & Biosimilar Drugs
10 déc. 2024 10h46 HE
|
Research and Markets
Dublin, Dec. 10, 2024 (GLOBE NEWSWIRE) -- The "Pharmaceutical Drying Equipment Market Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.The Pharmaceutical Drying...
GCC Pharmaceutical Market Clinical Trials Outlook 2030 - Branded & Imported Drug Dominate GCC Pharmaceutical Market Landscape
06 déc. 2024 08h54 HE
|
Research and Markets
Dublin, Dec. 06, 2024 (GLOBE NEWSWIRE) -- The "GCC Pharmaceutical Market Opportunity & Clinical Trials Outlook 2030" report has been added to ResearchAndMarkets.com's offering. The Gulf...
KRTL Holding Announces KRTL Biotech Facilitates FDA Registration of SIGMACORP as a U.S. Pharmaceutical Manufacturer
05 déc. 2024 09h00 HE
|
KRTL Holding Group
Lakewood, CO, Dec. 05, 2024 (GLOBE NEWSWIRE) -- KRTL Holding Group, Inc. (OTC: KRTL) announces that its subsidiary, KRTL Biotech Inc., has successfully registered Industria Químico Farmaceutica...
Jupiter Neurosciences, Inc. Announces Closing of $11 million Initial Public Offering
04 déc. 2024 16h56 HE
|
Jupiter Neurosciences, Inc.
Jupiter, Florida, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (Nasdaq: JUNS) (the “Company” or “Jupiter Neurosciences”), a clinical stage pharmaceutical company advancing a...
Jupiter Neurosciences, Inc. Announces Pricing of $11 million Initial Public Offering and Listing on Nasdaq
02 déc. 2024 19h00 HE
|
Jupiter Neurosciences, Inc.
Jupiter, Florida, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (Nasdaq: JUNS) (the “Company” or “Jupiter Neurosciences”), a clinical stage pharmaceutical company advancing a...
Scienture Holdings, Inc. Announces Private Placement of $3 Million of 10% Secured Convertible Debentures as Initial Tranche of $12 Million Offering and Entry into $50 Million Equity Line of Credit Agreement
26 nov. 2024 16h05 HE
|
Scienture Holdings, Inc.
Scienture Holdings to Receive Funding of Up to $12 Million From Private Placement of 10% Secured Convertible Debentures and Up to $50 Million from Equity Line of Credit Tampa, FL, Nov. 26, 2024 ...
A Milestone for KRTL Holding Group, Inc. (OTC: KRTL)
26 nov. 2024 09h00 HE
|
KRTL Holding Group
Lakewood, CO, Nov. 26, 2024 (GLOBE NEWSWIRE) -- KRTL Holding Group, Inc. (OTC: KRTL) announces a major strategic milestone: its subsidiary, KRTL Biotech Inc., has successfully completed the...
Digi-Tech Pharma & AI Conference 2025: Reimagining Pharma by Integrating Science and Technology (London, United Kingdom - May 28-29, 2025)
22 nov. 2024 04h07 HE
|
Research and Markets
Dublin, Nov. 22, 2024 (GLOBE NEWSWIRE) -- The "Digi-Tech Pharma & AI 2025" conference has been added to ResearchAndMarkets.com's offering. In this 8th edition as we explore the novel...